Stay updated on Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2, with no change to the study record content.
    Difference
    0.1%
    Check dated 2026-10-19T21:44:34.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1; the study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-13T04:14:35.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The history now includes a new revision entry v3.7.0 and removes the previous revision v3.6.6 from the visible history, reflecting an update to the record's release version.
    Difference
    0.1%
    Check dated 2026-09-21T22:32:54.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    A newer revision entry (v3.6.6) was added to the study record history, while the earlier entry (v3.6.5) was removed, reflecting a small update to the page's revision metadata.
    Difference
    0.1%
    Check dated 2026-08-31T16:37:00.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry labeled v3.6.5, replacing the previous v3.6.4. This update reflects the latest version metadata shown in the History tab.
    Difference
    0.1%
    Check dated 2026-08-10T12:25:29.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.4) was added to the history, replacing the previous v3.6.3 entry to reflect a minor update to the page history. This appears to be metadata about page revisions rather than a modification to the study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-07-27T06:16:36.000Z thumbnail image

Stay in the know with updates to Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.